Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA, U7 small nuclear 21 pseudogene (RNU7-21P) is a noncoding RNA considered a pseudogene related to the U7 small nuclear RNA gene family. Pseudogenes are typically nonfunctional remnants of genes that have lost their protein-coding potential due to mutations. U7 small nuclear RNA itself is essential for histone pre-mRNA processing as part of the U7 small nuclear ribonucleoprotein (snRNP) complex, but RNU7-21P does not encode a functional product. There is no evidence that RNU7-21P is expressed, involved in biological pathways, or is implicated in disease processes, nor is it considered a therapeutic target. Key details: - RNU7-21P is a **pseudogene**, not a functional gene or protein. - It is related to the **U7 small nuclear RNA** family, which is involved in histone pre-mRNA processing. However, only functional homologs like RNU7-1 are biologically relevant in this process[1][2][4][5]. - There are **no known drugs, disease associations, or targeted therapies** relevant to RNU7-21P. - It is **not a validated therapeutic target**, nor are there biological functions or mechanisms of action ascribed to it. Note: The functional gene with biological and disease relevance is **RNU7-1** (RNA, U7 small nuclear 1), which is involved in histone mRNA processing and can be implicated in rare disorders such as Aicardi-Goutières syndrome when mutated[1][2][5]. In contrast, RNU7-21P is a pseudogene and does not share these associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 21 pseudogene (RNU7-21P).